Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.

Martin JL, Julovi SM, Lin MZ, de Silva HC, Boyle FM, Baxter RC.

Breast Cancer Res. 2017 Aug 4;19(1):90. doi: 10.1186/s13058-017-0882-x.

2.

Insulin-like growth factor binding protein-3 links obesity and breast cancer progression.

Scully T, Firth SM, Scott CD, de Silva HC, Pintar JE, Chan-Ling T, Twigg SM, Baxter RC.

Oncotarget. 2016 Aug 23;7(34):55491-55505. doi: 10.18632/oncotarget.10675.

3.

Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.

Martin JL, de Silva HC, Lin MZ, Scott CD, Baxter RC.

Mol Cancer Ther. 2014 Feb;13(2):316-28. doi: 10.1158/1535-7163.MCT-13-0367. Epub 2013 Dec 12.

4.

Interaction between IGF binding protein-3 and TGFβ in the regulation of adipocyte differentiation.

de Silva HC, Firth SM, Twigg SM, Baxter RC.

Endocrinology. 2012 Oct;153(10):4799-807. Epub 2012 Aug 21.

PMID:
22910030

Supplemental Content

Loading ...
Support Center